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Despite limited evidence regarding their utility, infrared 
thermal detection systems (ITDS) are increasingly being 
used for mass fever detection. We compared tempera-
ture measurements for 3 ITDS (FLIR ThermoVision A20M 
[FLIR Systems Inc., Boston, MA, USA], OptoTherm Ther-
moscreen [OptoTherm Thermal Imaging Systems and In-
frared Cameras Inc., Sewickley, PA, USA], and Wahl Fever 
Alert Imager HSI2000S [Wahl Instruments Inc., Asheville, 
NC, USA]) with oral temperatures (>100°F = conﬁ  rmed 
fever) and self-reported fever. Of 2,873 patients enrolled, 
476 (16.6%) reported a fever, and 64 (2.2%) had a con-
ﬁ  rmed fever. Self-reported fever had a sensitivity of 75.0%, 
speciﬁ  city 84.7%, and positive predictive value 10.1%. At 
optimal cutoff values for detecting fever, temperature mea-
surements by OptoTherm and FLIR had greater sensitiv-
ity (91.0% and 90.0%, respectively) and speciﬁ  city (86.0% 
and 80.0%, respectively) than did self-reports. Correlations 
between ITDS and oral temperatures were similar for Opto-
Therm (ρ = 0.43) and FLIR (ρ = 0.42) but signiﬁ  cantly lower 
for Wahl (ρ = 0.14; p<0.001). When compared with oral tem-
peratures, 2 systems (OptoTherm and FLIR) were reason-
ably accurate for detecting fever and predicted fever better 
than self-reports.
A
dvancements in transportation coupled with the 
growth and movement of human populations enable 
efﬁ  cient transport of infectious diseases almost anywhere 
in the world within 24 hours (1). This recognition has 
prompted the evaluation of rapid mass screening methods 
to delay the importation of infection into healthcare set-
tings, communities, and countries (1–4). Because fever is 
a common indicator of many infectious diseases, the rapid 
identiﬁ  cation of fever is a major component of screening 
efforts. Such screening was used by many countries during 
the severe acute respiratory syndrome outbreak in 2003 and 
the inﬂ  uenza A pandemic (H1N1) 2009 outbreak (2,3,5–8). 
Despite widespread implementation of fever screening, 
its value for detecting highly communicable diseases has 
mainly been established through mathematical modeling 
rather than through studies in humans (9,10).
One approach to fever screening is to simply ask per-
sons if they have a fever. In healthcare settings, this in-
formation is routinely obtained in the chief complaint or 
review of symptoms and in some situations by querying 
persons as they enter the facility (11). In travel settings, 
many countries have used a written health declaration to 
screen travelers arriving at international ports of entry (2). 
However, limited information exists on the accuracy of 
self-reported fever, which is biased by its subjective na-
ture and reliance on travelers’ awareness of fever status 
and willingness to report (12,13). Indeed, a clinical trial 
suggested that traditional thermometry is superior to self-
reported fever for identifying patients with seasonal inﬂ  u-
enza (14). However, traditional thermometry methods are 
time-consuming and require close contact with potentially 
infectious patients.
Infrared thermal detection systems (ITDS) offer a po-
tentially useful alternative to contact thermometry. This 
technology was used for fever screening at hospitals, air-
ports, and other mass transit sites during the severe acute re-
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spiratory syndrome and inﬂ  uenza A pandemic (H1N1) 2009 
outbreaks (2,3,5–8,15). ITDS appeared to enable early detec-
tion of febrile persons entering healthcare facilities, where 
the undetected introduction of communicable diseases can 
lead to outbreaks among patients and staff (5,16–18).
Although ITDS have the potential to serve as rapid, 
noninvasive screening tools for detecting febrile persons, 
previous studies provide conﬂ  icting information about their 
utility for mass fever screening (15,16,19–25). In addition, 
there are few published comparisons of the efﬁ  cacy of dif-
ferent ITDS and their suitability for mass fever screening 
(19). Finally, no studies on the relative accuracy of self-
reported fever and ITDS for fever screening or the value 
of combining these 2 methods have been published. These 
questions and the potential need to rapidly screen for fe-
ver during an emerging pandemic prompted us to conduct 
this study to validate different ITDS temperatures and self-
reported fevers with oral temperatures.
Methods
Study Setting
A cross-sectional study comparing 3 ITDS was con-
ducted in 3 urban tertiary-care hospital emergency depart-
ments in the United States: Albuquerque, New Mexico; 
Atlanta, Georgia; and Chicago, Illinois. Emergency depart-
ments were selected as the evaluation setting because of a 
potential high prevalence of fever compared with its preva-
lence in healthy populations and the routine measurement 
of each patient’s oral temperature. The 3 hospitals were 
selected because of their estimated patient volume of >200 
patients per day.
Human Subject Research Protections
The study was approved by the Institutional Review 
Board (IRB) of the Centers for Disease Control and Pre-
vention (CDC) and the IRBs of the hospitals in Atlanta and 
Chicago. The Albuquerque hospital’s IRB reviewed the 
protocol but deferred to CDC’s IRB for approval.
Device Selection
ITDS were selected for evaluation through a competi-
tive bidding process. Selection criteria included speciﬁ  ca-
tions suitable for fever screening: view ﬁ  eld captures hu-
man heights (0.5–2.5 meters), temperature discrimination 
<0.2°C, smallest available sensor temperature range en-
compassing human temperatures (–40°C to 120°C), tripod/
stationary mount, operational distance >2 meters, internal/
external calibration standards, temperature capture time 
<1 second, and price <$25,000. Of 6 devices submitted to 
CDC, 3 met the above criteria and were selected for test-
ing: the FLIR ThermoVision A20M (FLIR Systems Inc., 
Boston, MA, USA), the OptoTherm Thermoscreen (Op-
toTherm Thermal Imaging Systems and Infrared Camer-
as Inc., Sewickley, PA, USA), and the Wahl Fever Alert 
Imager HSI2000S (Wahl Instruments Inc., Asheville, NC, 
USA). Manufacturers provided training and consultation 
on the assembly and operation of the ITDS per company 
practices but were otherwise uninvolved in the study.
Participants and Eligibility
Adults (>18 years of age) were recruited consecutively 
among patients who sought care at the emergency depart-
ments of 1 hospital in each city: Chicago (September 15–
29, 2008), Atlanta (October 6–24, 2008), and Albuquerque 
(February 17–26, 2009). Patients were approached after 
they had been registered in the emergency department from 
7:00 AM to 11:00 PM, 7 days per week, at all 3 sites and were 
enrolled in the study if they were willing to participate and 
gave verbal consent. Patients who were nonambulatory, 
mentally incompetent, arrested or incarcerated, <18 years 
of age, or required immediate medical attention were ex-
cluded from the study. Pregnant women were excluded in 
Chicago and Atlanta at the request of the hospitals’ IRBs.
Sample Size
We estimated that 61 febrile patients were necessary 
to evaluate the sensitivity of ITDS for fever detection (as-
sumed to be 80% from previous research) to within ±10% 
with 95% conﬁ  dence. With an estimated fever prevalence 
of 2% among a population of patients at emergency depart-
ments, a total sample size of ≈3,000 patients was needed 
for the study.
Temperature Measurements
The 3 ITDS were positioned at the optimal distance 
(2–3 m) from each participant as recommended by the 
manufacturers. Each ITDS camera ﬁ  eld of view was pre-
set to capture the patient’s face and neck. Participants 
were asked to remove eyeglasses and hats and instructed 
to stand facing the cameras until temperature measure-
ments from all 3 devices had been recorded.
To account for ambient temperature, the Wahl device 
was manually calibrated on each morning before data col-
lection, per manufacturer recommendation. In Albuquer-
que, where room temperatures varied during the day, the 
Wahl was additionally calibrated after noticeable changes 
in ambient temperature. The OptoTherm and FLIR have 
automated calibration systems to adjust for ambient condi-
tions, diurnal variations in temperature, and thermal drift 
and therefore did not require manual calibration.
Unadjusted skin temperatures detected by ITDS were 
included in the analysis to enable direct comparison with 
oral temperature measurements. The FLIR and Wahl cam-
eras did not display ﬁ  xed temperature readings but rather 
readings that ﬂ  uctuated by tenth of a degree increments. 
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For these 2 cameras, operators recorded the highest temper-
ature displayed for each person. Measurements recorded by 
the FLIR during periods when the camera was not properly 
focused were excluded from the analysis.
Oral temperatures were measured by clinical staff us-
ing a DinaMap ProCare digital thermometer (General Elec-
tric Company, Freiburg, Germany) in Albuquerque and 
Atlanta and a Welch Allyn SureTemp Plus 692 Electronic 
Thermometer (Welch Allyn Inc, San Diego, CA, USA) in 
Chicago, per each hospital’s established patient care stan-
dard. ITDS temperature measurements were taken either 
immediately after (Chicago and Atlanta) or just before (Al-
buquerque) each oral measurement. Conﬁ  rmed fever was 
deﬁ  ned as an oral temperature >100°F (>37.8°C). Room 
temperatures were recorded hourly by using a standard 
digital room thermometer.
Patient Self-Reports
Upon enrollment, patients were asked, “Do you feel like 
you have a fever now?” (self-reported fever) and whether 
they had taken medication for pain or fever (analgesic or 
antipyretic drugs) in the previous 8 hours. When needed, 
patients were given examples of trade and generic names 
of common antipyretic drugs. Their responses, along with 
each patient’s age and sex, date, and time of temperature 
measurement were recorded.
Data Analysis
Symptom questionnaire responses, oral temperature 
measurements, and ITDS-recorded data were entered into 
an Excel (Microsoft Corp., Redmond, WA, USA) database 
and analyzed by using SAS Version 9.2 (SAS Institute Inc, 
Cary, NC, USA). Patient responses of “Don’t know” to the 
question, “Do you feel like you have a fever now?” were 
analyzed as “No.” ITDS and oral temperature measure-
ments were compared by using descriptive statistics and 
bivariate analysis (χ2 tests, t tests, and correlations). Gen-
eralized linear modeling was used to investigate the effects 
of covariates and potential confounders (age, sex, recent 
antipyretic use, study site, self-reported fever, time of day, 
and room temperature) on temperature measurements and 
to identify factors that inﬂ  uenced the difference between 
oral and ITDS temperature measurements, given site-spe-
ciﬁ  c effects.
Sensitivity (the proportion of those with conﬁ  rmed fe-
ver who were identiﬁ  ed as febrile by ITDS) and speciﬁ  city 
(the proportion of those without conﬁ  rmed fever who were 
identiﬁ  ed as nonfebrile by ITDS) were calculated and used 
to plot the receiver operating characteristic (ROC) curves 
for all possible fever temperature thresholds on each ITDS. 
Optimal ITDS fever thresholds were deﬁ  ned as the tem-
perature that yielded the highest combined sensitivity and 
speciﬁ  city for fever detection for each device as determined 
by the ROC curves. Positive predictive value (PPV), the 
proportion of patients identiﬁ  ed as febrile by ITDS who had 
a conﬁ  rmed fever by oral temperature, was compared with 
self-report. The accuracies (sum of sensitivity and speciﬁ  c-
ity) of the following 3 fever screening methods were com-
pared by using oral thermometry as reference: 1) self-re-
ported fever, 2) ITDS at optimal fever detection threshold, 
and 3) combination of ITDS and self-reported fever with a 
positive result on either method considered a fever.
Results
Of 3,345 eligible patients, we enrolled a total of 2,873 
(85.9%): 1,511 (52.6%) in Chicago, 1,040 (36.2%) in 
Atlanta, and 322 (11.2%) in Albuquerque. The remain-
ing 472 (14.1%) patients refused to participate. Men ac-
counted for 1,514 (52.7%) participants; the mean age was 
42 years (range 18–92 years). The mean oral temperature 
was 97.9°F (range 92.8°F–104.4°F); 64 (2.2%) patients 
had conﬁ  rmed fever, including 48 (10.1%) of 476 patients 
reporting fever. Antipyretic or analgesic drug use within 8 
hours was reported by 1,121 (39.0%) patients, including 
225 (45.8%) who self-reported fever and 39 (60.9%) who 
had conﬁ  rmed fever.
Correlations of ITDS and oral temperatures were simi-
lar for OptoTherm (ρ = 0.43) and FLIR (ρ = 0.42) but sig-
niﬁ  cantly lower for Wahl (ρ = 0.14; p<0.001). The areas 
under the ROC curves (AUC) for OptoTherm (96.0%) and 
FLIR (92.0%) were not signiﬁ  cantly different but were sig-
niﬁ  cantly greater than the AUC of Wahl (78.2%; p<0.001; 
Figure 1). At their respective optimal threshold tempera-
tures, sensitivities of fever detection of the 3 ITDS were not 
signiﬁ  cantly different from each other, but speciﬁ  cities and 
PPVs of OptoTherm and FLIR were signiﬁ  cantly higher 
than those of Wahl (Table 1; p<0.001). At ﬁ  xed speciﬁ  ci-
ties, the sensitivities of each ITDS varied (Figure 2).
Compared with oral thermometry, sensitivity for self-
reported fever was 75%, speciﬁ  city was 84.7%, and PPV 
was 10.1%. Sensitivities of the 3 ITDS at their respective 
optimal thresholds did not differ signiﬁ  cantly from that 
of self-reported fever (Table 1). However, speciﬁ  cities 
and PPVs of OptoTherm and FLIR at optimal thresholds 
were signiﬁ  cantly greater than those of self-reported fever 
(p<0.001 for both comparisons), and speciﬁ  city and PPV of 
Wahl were signiﬁ  cantly lower than those of self-reported 
fever (p<0.001). The addition of self-report decreased the 
accuracy of fever detection at optimal thresholds for FLIR 
and OptoTherm (increase in sensitivity was less than de-
crease in speciﬁ  city) but improved accuracy for Wahl with 
a greater increase in sensitivity than the decrease in speci-
ﬁ  city (Table 1). Conversely, adding OptoTherm or FLIR 
temperature measurements to self-reported fever increased 
accuracy, but adding Wahl temperature measurements de-
creased accuracy (Table 1).
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Bivariate analyses revealed higher oral and ITDS 
temperatures among younger patients and later in the day 
(Table 2). Oral temperatures were higher in women, and 
ITDS temperature measurements were higher in men. 
ITDS temperature measurements increased with increasing 
room temperatures. Temperatures detected by oral ther-
mometers, OptoTherm, and FLIR were higher in patients 
who reported recent antipyretic or analgesic drug use.
When we controlled for study site, multivariate analy-
ses showed that 2 variables (sex and room temperature) 
were most strongly (p<0.001) associated with the size of 
the gap between oral and ITDS temperature measurements 
(Table 3). Smaller differences between ITDS and oral 
temperatures were found among men than among women. 
Differences between ITDS and oral temperatures became 
smaller with increasing room temperatures and as the day 
progressed (with the exception of FLIR). Site-speciﬁ  c ef-
fects indicated that, on average, differences between ITDS 
and oral temperatures were smaller among participants 
from Albuquerque and Atlanta than among those from 
Chicago. With the exception of Wahl measurements, the 
difference between ITDS and oral temperatures was greater 
in older patients. Differences between oral and OptoTherm 
temperatures tended to be smaller for those reporting anti-
pyretic drug use.
Discussion
Our evaluation of 3 ITDS in emergency department 
settings found that the FLIR and OptoTherm reliably iden-
tiﬁ  ed elevated body temperatures. The high AUCs for these 
2 systems suggest that they can differentiate between fe-
brile and afebrile persons with relatively high sensitivity 
and speciﬁ  city at an optimal fever cutoff. The relatively 
high correlation with oral temperature measurement also 
supports the utility of these 2 ITDS, which predicted fe-
ver better than self-reports of patients and more accurately 
alone than in combination with self-reported fever.
Our study is one of few that simultaneously examined 
the effects of multiple external and internal factors (age, 
sex, time of day, room temperature, and antipyretic drug 
use) on ITDS and oral temperature measurement accuracy. 
We found that ITDS and oral temperature measurements 
were strongly inﬂ  uenced by site and time of day, which may 
be a real effect or a result of variations in oral measurement 
techniques. The effects of age and time of day on body 
temperature found in this study have been well established 
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Figure 1. Receiver operating characteristic (ROC) curves of 3 
infrared thermal detection systems (ITDS) for detecting fever (oral 
temperature >100°F): FLIR ThermoVision A20M (FLIR Systems 
Inc., Boston, MA, USA), OptoTherm Thermoscreen (OptoTherm 
Thermal Imaging Systems and Infrared Cameras Inc., Sewickley, 
PA, USA), and Wahl Fever Alert Imager HSI2000S (Wahl 
Instruments Inc., Asheville, NC, USA). CI, conﬁ  dence interval. 
Table 1. Comparisons of 3 infrared thermal detection system results and self-reported fever with oral temperature among patients in 3 
emergency departments, USA, 2008–2009* 
Characteristics
OptoTherm,  
n = 2,507 patients
FLIR, 
n = 2,515 patients
Wahl,
n = 2,061 patients
Self-reported fever, 
n = 2,389 patients
Mean temperature, °F (SD) 94.3 (1.26) 95.7 (1.38) 89.4 (2.56) –
Optimal fever threshold, °F 95.3 96.4 89.3 –
Fever (oral temperature >100°)
  No. (%) identified as febrile by each method 275 (11.0) 247 (9.8) 577 (28.0) 404 (16.9)
  Sensitivity (95% CI) 91.0 (85.0–97.0) 90.0 (84.0–97.0) 80.0 (76.0–85.0) 75.0 (64.4–85.6)
  Specificity (95% CI) 86.0 (81.0–90.0) 80.0 (76.0–84.0) 65.0 (61.0–69.0) 84.7 (83.4–86.1)
  Positive predictive value (95% C) 17.9 (13.6–22.2) 18.4 (13.7–23.0) 5.7 (4.1–7.3) 10.1 (7.4–12.8)
  Negative predictive value (95% CI) 99.6 (99.3–99.8) 99.5 (99.1–99.7) 99.1 (98.6–99.5) 99.3 (98.9–99.6)
Febrile by either ITDS or self-report
  No. (%) identified as febrile by each method 597 (23.8) 586 (23.3) 793 (38.5) –
  Sensitivity (95% CI) 93.8 (87.8–99.7) 89.1 (81.4–96.7) 93.8 (87.8–99.7) –
  Specificity (95% CI) 78.0 (76.4–79.5) 78.4 (76.9–80.0) 63.3 (61.6–65.1) –
  Positive predictive value (95% CI) 9.0 (6.9–11.2) 8.8 (6.8–11.3) 5.6 (4.3–7.1) –
  Negative predictive value (95% CI) 99.8 (99.5–99.9) 99.7 (99.3–99.9) 99.8 (99.4–99.9) –
*OptoTherm Thermoscreen (OptoTherm Thermal Imaging Systems and Infrared Cameras Inc., Sewickley, PA, USA), FLIR ThermoVision A20M (FLIR 
Systems Inc., Boston, MA, USA), and Wahl Fever Alert Imager HSI2000S (Wahl Instruments Inc., Asheville, NC, USA). CI, confidence interval; ITDS, 
infrared thermal detection system. RESEARCH
by previous research (26–28). We observed strong associa-
tions between ITDS and room temperatures. Similar obser-
vations with room temperatures and extended exposure to 
hot or cold environments have been reported (22,25,29,30). 
The unexpected association between higher temperature 
measurements (oral and OptoTherm) and recent antipyretic 
drug use may result from patients with higher fevers tak-
ing antipyretic drugs, inadequate antipyretic drug dosage, 
or both. The ﬁ  nding that men had relatively higher ITDS 
measurements than women has not been previously report-
ed and may be because of differences in facial hair, use of 
cosmetics, or subcutaneous fat composition (31). Similar 
associations across multiple ITDS underscore the strength 
of these ﬁ  ndings. By controlling for these covariates, we 
were able to measure the relationship between ITDS and 
oral temperatures with greater precision.
Although the sensitivity, speciﬁ  city, and AUC of the 
devices we tested were similar to those found in previous 
studies, we observed a higher correlation between ITDS 
temperature measurements and conﬁ  rmatory temperature 
measurements (15,16,19–25). Several factors may have 
contributed to these differences. The higher correlation 
between ITDS and body temperatures reported here may 
be related to the use of oral temperature measurement as 
reference. Although oral temperature measurements bet-
ter reﬂ  ect core temperatures than infrared tympanomet-
ric measurements, most previous investigations of ITDS 
have used the latter as reference (19,23,24,32–35). The 
preference for oral temperatures as reference is supported 
by an evaluation of methods for measuring body tempera-
ture conducted by the American College of Critical Care 
Medicine and the Infectious Diseases Society of America; 
researchers found that rectal temperatures were the most 
accurate of the peripheral thermometry methods, fol-
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Figure 2. Enhanced view of receiver operating characteristic curves 
of 3 infrared thermal detection systems for detecting fever (oral 
temperature >100°F) showing sensitivities at false-positive rates 
(FPR) of 1%, 5%, and 10%. Red, FLIR ThermoVision A20M (FLIR 
Systems Inc., Boston, MA, USA); blue, OptoTherm Thermoscreen 
(OptoTherm Thermal Imaging Systems and Infrared Cameras 
Inc., Sewickley, PA, USA); and green, Wahl Fever Alert Imager 
HSI2000S (Wahl Instruments Inc., Asheville, NC, USA).
Table 2. Associations between temperature measurements by 3 infrared thermal detection systems and potential covariates, using 
bivariate analysis, among patients in 3 emergency departments, 2008–2009* 
Characteristics
Oral thermometer, 
n = 2,873 patients
OptoTherm, 
n = 2,809 patients
FLIR, 
n = 2,314 patients
Wahl,
n = 2,848 patients
Gender
  Male mean temperature, °F (SD) 97.85 (0.91) 94.36 (1.25) 95.77 (1.33) 89.52 (2.40)
  Female mean temperature, °F (SD) 97.95 (0.87) 94.19 (1.27) 95.59 (1.40) 89.23 (2.73)
  p value (t test) 0.002 <0.001 0.002 0.003
Age
  Correlation coefficient r –0.12 –0.15 –0.10 –0.10
 p  value <0.001 <0.001 <0.001 <0.001
Time of day
  Correlation coefficient r 0.08 0.24 0.19 0.27
 p  value <0.001 <0.001 <0.001 <0.001
Antipyretic/analgesic use
  Yes (mean temperature °F) (SD) 97.96 (1.01) 94.39 (1.34) 95.76 (1.47) 89.47 (2.61)
  No (mean temperature °F) (SD) 97.86 (0.81) 94.22 (1.20) 95.64 (1.32) 89.35 (2.54)
  p value (t test) 0.003 <0.001 0.048 0.21
Room temperature
  Correlation coefficient r 0.01 0.19 0.19 0.19
 p  value 0.77 <0.001 <0.001 <0.001
Oral temperature
  Correlation coefficient r  – 0.43 0.42 0.14
 p  value – <0.001 <0.001 <0.001
*FLIR ThermoVision A20M (FLIR Systems Inc., Boston, MA, USA), OptoTherm Thermoscreen (OptoTherm Thermal Imaging Systems and Infrared 
Cameras Inc., Sewickley, PA, USA), and Wahl Fever Alert Imager HSI2000S (Wahl Instruments Inc., Asheville, NC, USA). Mass Fever Screening
lowed by oral, tympanic, and axillary temperature mea-
surements, respectively (32).
Many types of ITDS are available, ranging from in-
expensive hand-held point-and-shoot devices with laser 
sighting to hand-held cameras with light-emitting diode 
displays, wall-mounted cameras, and portable cameras on 
tripods such as the ones used in this study (19,23,29). To 
maximize potential efﬁ  cacy, we evaluated technically ad-
vanced ITDS that were recently developed for human tem-
perature detection. Other studies used more basic systems 
and did not compare different devices. Although the costs 
of the OptoTherm and FLIR were comparable at $22,000 
and $16,000 per system, respectively, the Wahl was rela-
tively less expensive ($8,000). Testing 3 different models 
at various price ranges allowed us to demonstrate substan-
tial differences among ITDS. These differences are likely 
to affect their sensitivity and utility for fever screening. The 
systems used in this study require the person to stand in 
front of the camera for ≈2–3 seconds to capture a tempera-
ture. Other differences, such as moving persons, could have 
further affected the sensitivity of ITDS for fever detection.
Although addition of a health declaration form would 
allow screening to also consider recent travel history, 
previous fever, and other symptoms or illness exposures, 
health declarations have variable compliance rates and 
depend on a person’s ability to understand questions and 
accurately assess symptoms as well as willingness to re-
port (12,13,36,37). In our study, in which patients had no 
disincentive to report, we found that one fourth of febrile 
patients did not report having fever, which suggests true 
unawareness of fever among some persons. Only one tenth 
of those who reported having a fever were actually found 
to be febrile. Our results, therefore, probably underestimat-
ed the beneﬁ  t of ITDS over self-reports of fever. In other 
settings, ill persons may be less likely to report symptoms 
for fear of adverse consequences such as travel delays, in-
voluntary isolation of ill persons, or quarantine of exposed 
contacts. In settings such as travel sites (e.g., airports) and 
the workplace, ITDS could provide an objective means for 
the mass detection of fever as part of a comprehensive pub-
lic health screening strategy because ITDS had greater ac-
curacy than self-reports.
Mass health screening during a pandemic will cer-
tainly be inﬂ   uenced by several other factors, including 
perceived and actual pandemic severity, as well as the po-
tential consequences of illness detection, either negative or 
positive, which can affect the sensitivity of screening that 
uses self-report. If being detected as febrile is perceived 
as harmful, travelers may hide their symptoms (12). Alter-
natively, during a pandemic with high mortality rates, in-
centives for reporting symptoms might be present, such as 
access to scarce antiviral medications and medical care. In 
both situations, a comprehensive screening approach may 
be necessary, which uses ITDS for fever screening and a 
health questionnaire to detect other symptoms or exposures 
that would increase speciﬁ  city of the screening process. 
Finally, the usefulness of any infectious disease screen-
ing must take into account temperature ﬂ  uctuations, use of 
antipyretic medications, transmission risks, prevalence of 
infections, and asymptomatic infections.
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Table 3. Association between measured temperature, difference, and covariates, general linear regression with site-specific fixed
effects in 3 emergency departments, USA, 2008–2009
Characteristics
Oral, 
n = 1,865 
patients
OptoTherm, 
n = 1,851 
patients
Difference
(oral–OptoTherm)
FLIR,
n = 1,360 
patients
Difference
(oral–FLIR)
Wahl,
n = 1,856 
patients
Difference
(oral–Wahl)
Intercept (SE) 98.220
(0.936)
15.027 
(3.467)
14.426 
(1.337)
15.777 
(4.150)
14.309 
(1.559)
13.160 
(6.541)
21.769 
(2.489)
Variable in model*
Oral temperature – 0.701† – 0.693† – 0.645† –
Male sex –0.055‡ 0.254† –0.271† 0.237† –0.260† 0.501† –0.522†
Age 0.011‡ –0.160§ 0.019§ –0.029§ 0.034§ –0.001‡ 0.005‡
Age squared –0.0002§ 0.0001‡ –0.0002‡ 0.0003§ –0.0004§ –0.002‡ 0.0001‡
Site¶    
 Albuquerque –0.498† 0.915† –1.061† –0.214§ 0.058‡ 4.256† –4.431†
 Atlanta –0.309† 0.514† –0.603† 0.302§ –0.399† 0.043‡ –0.149‡
Time of day 0.104§ 0.156§ –0.126§ 0.131§ –0.100‡ 0.352† –0.315†
Time of day squared –0.003§ –0.004§ 0.003‡ –0.003‡ 0.002‡ –0.008§ 0.007§
Antipyretic use 0.106§ 0.137§ –0.106§ 0.118* –0.086‡ 0.075‡ –0.039‡
Room temperature –0.010‡ 0.133† –0.137† 0.160† –0.162† 0.131† –0.135†
Self-reported fever (No) 0.432† 0.148§ 0.022‡ 0.149‡ 0.003‡ –0.115‡ 0.264§
*FLIR ThermoVision A20M (FLIR Systems Inc., Boston, MA, USA), OptoTherm Thermoscreen (OptoTherm Thermal Imaging Systems and Infrared 
Cameras Inc., Sewickley, PA, USA), and Wahl Fever Alert Imager HSI2000S (Wahl Instruments Inc., Asheville, NC, USA). Value of ȕ coefficient (ȕ) for 
each variable in the model is listed in the columns.  
†p<0.001. 
 ‡Not significant (p>0.05). 
§p<0.05.  
¶Referent site is Chicago. RESEARCH
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This study had several limitations. Measurement er-
ror resulting from variation in digital oral thermometer 
measurement and technique may have decreased the cor-
relation between ITDS and oral temperature measurements 
(38). For FLIR and Wahl, varying readouts by different op-
erators may have led to increased variability. This method, 
although necessary for direct temperature comparisons, 
may have decreased the accuracy of FLIR and Wahl. Use 
of alarm features as recommended by the manufacturers 
could minimize these differences but might lead to more 
false-positive results. In addition, unlike the other 2 devic-
es, Wahl required calibration to ambient temperature once 
per day, but room temperatures varied within the day. We 
evaluated only systems submitted by manufacturers to the 
bid process, thus limiting the generalizability of our results 
to other devices.
To assess the sensitivity and speciﬁ  city of different 
ITDS for fever detection and to determine their optimal 
thresholds, we validated each measurement by oral ther-
mometry, which required a clinical setting. Thus, gener-
alizability to settings such as airports and border crossings 
may be limited. Substantial delays to travelers and ethical 
concerns such as follow-up treatment made it impractical 
to conduct this study in an airport setting. In addition, al-
though a few studies have examined screenings in airports, 
they conﬁ  rmed temperature only in febrile persons, thus 
sensitivity and speciﬁ  city of ITDS could not be established 
from such studies.
The sensitivity and speciﬁ  city of screening by using 
ITDS are determined by the selected fever temperature 
cutoff, which tends to be 2–3 degrees lower than the stan-
dard fever threshold because of differences between skin 
and core temperatures. Increasing or decreasing sensitivity 
causes a reciprocal change in speciﬁ  city. For example, low-
ering OptoTherm’s threshold from the optimal 95.7°F to 
94.5°F would achieve almost 100% sensitivity but would 
reduce speciﬁ  city to 63.6% and increase the false-positive 
rate to 36.4%; to reach near 100% speciﬁ  city with the Op-
toTherm by using cutoff of 100°F for ITDS, sensitivity de-
creases to 6.4%.
Maximizing accuracy by choosing the optimal cut-
off with the highest sensitivity and speciﬁ  city may not be 
practical in a real-world setting, considering the relative 
costs of false-positive and false-negative results. In settings 
where secondary evaluation is available or during a pan-
demic with high illness severity, ITDS temperature can be 
set at a lower cutoff to ensure fewer false negatives, each of 
which represents a potential public health threat. However, 
setting the cutoff to achieve very high sensitivity can result 
in many false positives, which could have adverse conse-
quences to the population being screened (e.g., unneces-
sary travel delays, missed work) and increase the workload 
of staff who are conducting the screening. In settings where 
conﬁ  rmatory testing may not be feasible or high costs may 
be associated with a false-positive result, a higher ITDS 
temperature cutoff may be preferable.
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